Recently, many people have thought that it is time to consider a patent reprieve for COVID-19 vaccines. In
my opinion, I can understand why many people argue about it, and I think allowing to use of vaccine
inventions freely is necessary for this emergency time.
On the one hand, the waiver of vaccine patents could indeed have a role in accelerating the end of the
pandemic. It can help to stop the spread of the virus COVID and prevent people from infection. Since the
more people inject the vaccine, the more people will be safe. Moreover, the period of pandemics has had a
severe impact on properties and people. The high- and upper-middle-income countries, which can place
substantial advance orders with the relatively small group of companies making vaccines, could easily
overcome the pandemic with their vaccine import and manufacture. But with the poorer nations, this period
can prolong due to their underprivileged things. As a result, the pandemic can not be stopped completely if
somewhere in the world still has it.
On the other hand, the pharmaceutical industry, and some researchers argue that temporary relief from patents
will not be necessary. Because these patents are a considerable effort in the long period, it is not easy to
transfer to others countries. No one can ensure a developing country can build up enough facilities for this
technology. In this instance, the patents are unuseful and harmful for both inventors and the poor countries.
To sum up, there are times when competition helps research and innovation; there are also times when it
needs to be set aside for the greater good. So the allowing use of vaccine inventions is reasonable and
essential at this time.
Recently,
many
people
have
thought
that it is
time
to consider a
patent
reprieve for COVID-19
vaccines
. In
my opinion, I can understand why
many
people
argue about it, and I
think
allowing to
use
of vaccine
inventions
freely
is necessary for this emergency time.
On the one hand, the waiver of
vaccine
patents
could
indeed
have a role in accelerating the
end
of the
pandemic. It can
help
to
stop
the spread of the virus
COVID
and
prevent
people
from infection. Since the
more
people
inject the
vaccine
, the more
people
will be safe.
Moreover
, the period of pandemics has had a
severe impact on properties and
people
. The high- and upper-middle-income countries, which can place
substantial advance orders with the
relatively
small
group of
companies
making
vaccines
, could
easily
overcome the pandemic with their
vaccine
import and manufacture.
But
with the poorer nations, this period
can prolong due to their underprivileged things.
As a result
, the pandemic can not be
stopped
completely if
somewhere in the world
still
has it.
On the other hand
, the pharmaceutical industry, and
some
researchers argue that temporary relief from patents
will not be necessary.
Because
these
patents
are a considerable effort in the long period, it is not easy to
transfer to others countries. No one can ensure a
developing country
can build up
enough
facilities for this
technology. In this instance, the
patents
are unuseful and harmful for both inventors and the poor countries.
To sum up, there are
times
when competition
helps
research and innovation; there are
also
times
when it
needs to
be set
aside for the greater
good
.
So
the allowing
use
of
vaccine
inventions is reasonable and
essential at this
time
.